NCT07216378 Treatment of Angioedema Attacks in Pediatric (Ages 2-11) Post-Trial and Naive Patients With HAE With Sebetralstat Status AVAILABLE Phase N/A
NCT07009262 A Study Observing US Patients With HAE Type I or II Who Take Icatibant to Treat HAE Attacks Status COMPLETED Phase N/A
NCT06806657 Safety Study in Subjects ≥ 12 Years of Age With Hereditary Angioedema Switching to Garadacimab Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT06690047 Treatment of Hereditary Angioedema Prodrome with Recombinant C1-esterase Inhibitor (Ruconest) Status COMPLETED Phase PHASE4
NCT06634420 HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06628713 Treatment of Angioedema Attacks in Adolescent and Adult Patients 12 Years and Older With HAE Type I or II With Sebetralstat Status APPROVED_FOR_MARKETING Phase N/A
NCT06467084 Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With HAE Type I or II Status COMPLETED Phase PHASE3
NCT06415448 Donidalorsen Expanded Access Program for Patients With Hereditary Angioedema Status AVAILABLE Phase N/A
NCT06414252 Social Evaluated Cold Pressor Test in Hereditary Angioedema Patients Status COMPLETED Phase N/A
NCT06343779 Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema Status COMPLETED Phase PHASE3
NCT06262399 Long-Term Follow-Up (LTFU) of Subjects Treated With NTLA 2002 Status ENROLLING_BY_INVITATION Phase N/A
NCT06007677 A Long-term Study of STAR-0215 in Participants With Hereditary Angioedema Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05695248 A Study of Navenibart (STAR-0215) in Participants With Hereditary Angioedema Status COMPLETED Phase PHASE1/PHASE2
NCT05691361 Safety, Tolerability, PK, PD of ADX-324 in Healthy Volunteers and Hereditary Angioedema Patients Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05511922 PK Subtrial in Adolescent Patients With HAE Type I or II Participating in the KVD900-302 Trial Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05505916 An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE) Status ACTIVE_NOT_RECRUITING Phase PHASE3